Medline Inc. Reports Strong Q3 2026 Growth Driven by New Customer Implementations
Medline Inc. (MDLN) reported robust third-quarter results for 2026, with net sales reaching $7.9 billion, a 10.4% increase compared to the previous year. This growth was primarily fueled by new customer implementations and expansion within existing accounts across its Supply Chain Solutions and Medline Brand segments. Adjusted EBITDA rose 11.8% to $1.0 billion, supported by strong sales performance and tariff refunds. Despite the top-line strength, management noted several headwinds affecting margins, including elevated diesel prices due to Middle East conflicts and inflationary pressures on inventory costs expected to weigh more heavily in Q4. Additionally, a one-time $80 million impact from the Tracy Fire affected net income. However, the company raised its full-year organic sales guidance to 10%–10.5% and continues to invest significantly in distribution automation and capacity expansion.
Tickers: $MDLN
Topics: adjusted EBITDA net sales organic growth segment performance